Doyle T D, Brunner C A, Vick J A
Food and Drug Administration, Division of Research and Testing, Washington, DC 20204.
Biomed Chromatogr. 1991 Jan;5(1):43-6. doi: 10.1002/bmc.1130050110.
Racemic phenylpropanolamine was resolved on a high performance liquid chromatographic (HPLC) chiral stationary phase (CSP) as the 3,5-dinitrophenyl ureide derivative. The CSP was prepared by a simple in situ procedure in which (R)-(1-naphthyl)ethyl isocyanate was bound to aminopropyl silanized silica through a urea linkage. The enantiomeric ureides were prepared by a room-temperature, 60-second procedure, accomplishing simultaneous extraction and derivatization and utilizing achiral 3,5-dinitrophenyl isocyanate as reagent. Baseline resolution was readily achieved under normal phase conditions, with a separation factor (alpha) of 1.16 and a resolution factor (RS) of 2.2. Elution was complete within 10 min. A limit of detection, by UV at 235 nm, of 250 pg per isomer was established. Feasibility of the procedure for plasma determinations was demonstrated by assay of samples from a canine subject.
外消旋苯丙醇胺以3,5-二硝基苯基脲衍生物的形式在高效液相色谱(HPLC)手性固定相(CSP)上进行拆分。该CSP通过一种简单的原位方法制备,即将(R)-(1-萘基)乙基异氰酸酯通过脲键连接到氨丙基硅烷化硅胶上。对映体脲化物通过室温下60秒的方法制备,实现了同时萃取和衍生化,并使用非手性的3,5-二硝基苯基异氰酸酯作为试剂。在正相条件下很容易实现基线分离,分离因子(α)为1.16,分离度因子(RS)为2.2。洗脱在10分钟内完成。通过在235nm处的紫外检测,确定每种异构体的检测限为250pg。通过对犬类受试者的样品进行分析,证明了该方法用于血浆测定的可行性。